Prasol Chemicals IPO DRHP: ₹60 crore fresh issue; ₹1,232.59 crore FY26 revenue
- Prasol Chemicals files DRHP for ₹60 crore fresh issue to repay debt.
- FY26 revenue reached ₹1,232.59 crore; PAT surged to ₹83.12 crore.
- IPO opens on September 8, 2026, with listing scheduled for September 16.
- Key risks include high debt burden and facility underutilization.
*this image is generated using AI for illustrative purposes only.
Prasol Chemicals Limited, a forward-integrated manufacturer of acetone and phosphorous-based specialty chemicals, has filed its Draft Red Herring Prospectus (DRHP) for an initial public offering. The company plans to raise ₹60.00 crore through a fresh issue, primarily to repay existing borrowings and strengthen its balance sheet.
About the Company
Founded in 1992, Prasol Chemicals operates two manufacturing facilities in Maharashtra with an aggregate installed capacity of 98,644 metric tonnes per annum (MTPA). The company manufactures over 150 specialty chemical products across five key segments: Performance Chemicals, PICA (Paints, Inks, Construction & Adhesives), Pharmaceuticals, Agrochemicals, and Home & Personal Care.
Prasol Chemicals serves a diversified customer base, attending to 1,618 customers in FY2026, up from 1,560 in FY2024. It exports to 69 countries and holds the Government of India’s 3 Star Export House certification. The company maintains a dedicated R&D team of 37 members, including PhD holders and chemists, with a pipeline of 40 products under development.
Financial Performance
The company has demonstrated significant growth in revenue and profitability over the past three years. Revenue from operations grew by approximately 40.65% from ₹876.57 crore in FY2024 to ₹1,232.59 crore in FY2026. Net profit after tax (PAT) surged by roughly 358.63%, rising from ₹18.13 crore in FY2024 to ₹83.12 crore in FY2026.
| Metric (₹ Crore) | FY2024 (Consolidated) | FY2025 (Consolidated) | FY2026 (Standalone) |
|---|---|---|---|
| Revenue from Operations | 876.57 | 1,012.49 | 1,232.59 |
| Profit Before Tax (PBT) | 33.51 | 59.29 | 111.90 |
| Net Profit (PAT) | 18.13 | 43.57 | 83.12 |
| Operating EBITDA Margin | 6.91% | NA | 11.30% |
Total assets increased from ₹626.36 crore in FY2024 to ₹839.28 crore in FY2026. Total equity rose to ₹448.51 crore in FY2026. However, operating cash flows showed volatility, declining from ₹115.61 crore in FY2024 to ₹22.26 crore in FY2025 before recovering to ₹49.47 crore in FY2026.
Why the Company Is Raising Funds
The entire quantified proceeds of ₹60.00 crore from the fresh issue are earmarked for the repayment or pre-payment of certain borrowings availed by the company. This move aims to deleverage the balance sheet, reduce debt servicing costs, and improve return on capital employed. Any residual funds will be utilized for general corporate purposes, including business development and strategic initiatives.
Business Strengths
- Diversified Portfolio: Over 150 products across five end-use segments reduce dependency on any single sector.
- Global Reach: Exports to 69 countries with a 3 Star Export House certification.
- R&D Capability: A team of 37 researchers with 40 products in the development pipeline.
- Customer Base: Served 1,618 customers in FY2026, with top 10 customers contributing only 23.68% of revenue.
- Sustainability: Achieved a 93% score in EcoVadis sustainability rating.
Key Risks
- Facility Dependency: Operations are concentrated in two Maharashtra facilities. The Mahad facility was shut down for approximately six months in FY2024 due to gas leakage incidents.
- High Debt Burden: As of July 15, 2026, total outstanding indebtedness stood at ₹343.67 crore. Breach of financial covenants could trigger immediate repayment obligations.
- Cash Flow Volatility: Significant fluctuations in operating cash flows pose liquidity risks.
- Capacity Underutilization: The Mahad facility operated at 44.09% capacity utilization in FY2026 and reported losses of ₹12.17 crore.
- Contingent Liabilities: Aggregate contingent liabilities were ₹109.12 crore as of March 31, 2026, constituting 24.33% of net worth.
Important IPO Dates
- IPO Opening Date: 08-Sep-2026
- IPO Closing Date: 10-Sep-2026
- Allotment Date: 11-Sep-2026
- Listing Date: 16-Sep-2026
Offer Details
- Issue Type: Initial Public Offering (IPO)
- Fresh Issue Size: ₹60.00 Crore
- Offer for Sale (OFS): Not Available
- Price Band: Not Available
Bottom Line
Prasol Chemicals presents a strong financial turnaround with robust revenue and profit growth over the last two years. The ₹60 crore fresh issue aims to address a significant debt burden of ₹343.67 crore. While the diversified product portfolio and global export presence offer resilience, investors must weigh these strengths against risks related to facility concentration, past regulatory shutdowns, and high contingent liabilities.
How will the repayment of ₹60 crore in borrowings impact Prasol Chemicals' debt-to-equity ratio and interest coverage ratios post-IPO?
What specific operational improvements or safety protocols will be implemented to prevent future shutdowns at the Mahad facility, given its history of gas leakage incidents?
Given the volatility in operating cash flows, what strategies does management plan to employ to stabilize liquidity and ensure consistent working capital management?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
